A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
about
Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formationWFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activityAgrin binds BMP2, BMP4 and TGFbeta1Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cellsDistinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathwaysWISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activityPotential roles of BMP9 in liver fibrosisAbnormal Activation of BMP Signaling Causes Myopathy in Fbn2 Null MiceMulti-lineage MSC differentiation via engineered morphogen fields.Extracellular matrix protein anosmin promotes neural crest formation and regulates FGF, BMP, and WNT activitiesBMP9 is a proliferative and survival factor for human hepatocellular carcinoma cellsBRITER: a BMP responsive osteoblast reporter cell lineA rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum.sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair.Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndromeIn vivo ectopic bone formation by devitalized mineralized stem cell carriers produced under mineralizing culture conditionCoordinated regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by endogenous bone morphogenetic proteins.Initiation of BMP2 signaling in domains on the plasma membrane.Synergistic interaction between the fibroblast growth factor and bone morphogenetic protein signaling pathways in lens cells.Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathwayMechanical strain promotes osteoblast ECM formation and improves its osteoinductive potential.Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.Cathepsin-Mediated Alterations in TGFß-Related Signaling Underlie Disrupted Cartilage and Bone Maturation Associated With Impaired Lysosomal Targeting.A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors.BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive proteinDevelopment of an ALK2-biased BMP type I receptor kinase inhibitor.MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells.Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signalingFibrillin-1 Regulates Skeletal Stem Cell Differentiation by Modulating TGFβ Activity Within the Marrow Niche.A modular versatile chip carrier for high-throughput screening of cell-biomaterial interactionsBMP4 promotes prostate tumor growth in bone through osteogenesis.Coating of titanium implant materials with thin polymeric films for binding the signaling protein BMP2.In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors.Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophies.Identification of direct negative crosstalk between the SLIT2 and Bone Morphogenetic Protein-Gremlin signaling pathways.Variable signaling activity by FOP ACVR1 mutations.
P2860
Q24300318-1112E02D-6123-4D0E-B373-FC8126507466Q24305801-302E214D-4342-4EE9-B637-AE0EAD7BB66BQ24315763-9CFA758A-14AF-428D-BF89-26D2B5D3E8AFQ24337548-74C4045A-FCFA-467D-A5C4-11408CFF3599Q24621990-58B1D81D-907A-48C0-BDAB-4220EBCFA27EQ24635850-AE42B157-52B6-49A4-BE8B-75370486532CQ26998823-E6F3DD7A-6B38-4F08-AE2F-FF6DED24876CQ27310854-D64242EC-3877-49E4-968A-127B43F6FB39Q27327212-5D9F5F58-5043-4F2D-9159-41E5CF48572FQ28273253-41851EE4-6C75-4CE1-9500-C98AECE42363Q28296361-98B1A9F0-B979-4A27-9D36-240095870AEDQ28483777-D88433F2-44E7-476E-8DA5-CD1894CB8604Q33419686-4ABDB482-43B2-4E30-9CA1-6E0ED5A30E5EQ34285194-D810CCC5-1DBD-48E3-B6E7-1AD4BD5D89C9Q34313807-4FF954D4-BBE8-4B01-967C-0694230ADE38Q34341127-DD2B9F31-5379-4177-B6A4-3F9484FC34E4Q34579472-158D180C-111C-4909-BE6A-F9C16DFF2B08Q35108879-8BADA08B-872F-45BA-89A6-578A0BF8D611Q35846419-5B9A3FFA-7F25-4AB4-A1C6-75B971996ABFQ36063693-57C95801-9305-4672-AF04-DEC26E89578EQ36179224-FE2A8D84-82D6-4C58-AB02-CC3CAACC6FF3Q36412560-E6977A80-47FD-449A-8ECF-6922BCE9137AQ36625078-564E7EC6-0614-4E06-846D-02906374CF98Q36730987-D21F082F-EBE8-4842-8FBB-F2A846D46A14Q36976161-96900FB2-850C-4C7B-A029-CDABC82E6B51Q37052894-C36DF472-041C-43D0-B16F-A64AA28A6EF4Q37138985-EF6192BB-2996-4C16-9ED6-447603471D5DQ37179550-9BFA1548-516B-423F-8CAD-747972A22144Q37513815-53DF9DD7-5B59-42DA-AE3F-EE1114614FC5Q37592108-0402F9B4-D3B7-49C9-96FA-58986EFD8977Q38199567-58140610-AC06-4DC7-BEBA-105159E6FD77Q38809268-7D75F4A8-A4F6-410A-B756-0B7F3BE35E2AQ38851482-772B96FC-5E8B-4354-A57E-146920F378DDQ39244832-DC64899C-3878-4B1F-95EA-39E2840B93BAQ39525268-DF417C53-A8B5-47B1-BDD5-9CA5D59E9EC1Q39631313-AAA2623B-9B07-465B-B794-8ACC300BB118Q42242654-A49C9F81-116A-4440-AD50-DEFE3BA4F2EEQ45884269-BA7E3C3F-3201-40BC-BB91-F7D9A47B2182Q47215853-3574EE6A-254D-49CF-9466-9EB2C7014094Q47447929-14D8AC61-9A59-4CA3-B5A0-9D79A455C8E8
P2860
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@ast
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@en
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@nl
type
label
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@ast
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@en
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@nl
prefLabel
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@ast
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@en
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@nl
P2093
P2860
P356
P1433
P1476
A rapid and sensitive bioassay to measure bone morphogenetic protein activity.
@en
P2093
Daniel B Rifkin
Lior Zilberberg
Lynn Y Sakai
Peter ten Dijke
P2860
P2888
P356
10.1186/1471-2121-8-41
P577
2007-09-19T00:00:00Z
P5875
P6179
1033045183